Literature DB >> 14988605

Progression in lacunar stroke is related to elevated acute phase parameters.

Heinrich J Audebert1, Tina S Pellkofer, Martin L Wimmer, Roman L Haberl.   

Abstract

BACKGROUND AND
PURPOSE: Despite the small size of lacunar infarcts, progression of neurological deficits is a common problem in this stroke subtype. This investigation studied the frequency and the course of neurological deterioration as well as predictors and possible underlying pathomechanisms of early progression in lacunar stroke.
METHODS: Fourty-six consecutive patients with acute lacunar stroke were prospectively evaluated by daily clinical neurological examination including the National Institutes of Health Stroke Scale (NIHSS) and follow-up using the Barthel Index after 3 months. Progressive neurological deficit was defined as worsening by > or =1 point in the NIHSS for motor function. Progressive and stable patients were compared regarding clinical profile, inflammatory parameters (leukocytes, body temperature, C-reactive protein), coagulation parameters (fibrinogen, D-dimer, vWF, PTT), and glutamate plasma concentration, as well as blood glucose and blood pressure.
RESULTS: Eleven patients (23.9%) showed progression of stroke symptoms, 9 of these within the first 24 h after admission. The score on the NIHSS on admission was similar in patients with progressive stroke and stable patients, but significantly higher in the progressive stroke group on days 2 (p = 0.01), 3 (p = 0.001) and at discharge (p = 0.003). Deterioration was significantly associated with a higher leukocyte count (p = 0.012), higher body temperature (p = 0.031) and a higher fibrinogen concentration (p = 0.046) on admission. Barthel Index at discharge (p = 0.001) and after 90 days (p < 0.001) was significantly worse in the progressive stroke group.
CONCLUSIONS: Progression in lacunar stroke usually occurs within 24 h and may be related to an acute-phase response. The long-term prognosis of progressive stroke patients is persistently worse compared with patients with nonprogressive stroke. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14988605     DOI: 10.1159/000077012

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  19 in total

1.  What change in the National Institutes of Health Stroke Scale should define neurologic deterioration in acute ischemic stroke?

Authors:  James E Siegler; Amelia K Boehme; Andre D Kumar; Michael A Gillette; Karen C Albright; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-06-21       Impact factor: 2.136

2.  D-dimers increase in acute ischemic stroke patients with the large artery occlusion, but do not depend on the time of artery recanalization.

Authors:  David Skoloudík; Michal Bar; Daniel Sanák; Petr Bardon; Martin Roubec; Katerina Langová; Roman Herzig; Petr Kanovský
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

3.  Clinical manifestation of cancer related stroke: retrospective case-control study.

Authors:  Jeong-Min Kim; Keun-Hwa Jung; Kee Hong Park; Soon-Tae Lee; Kon Chu; Jae-Kyu Roh
Journal:  J Neurooncol       Date:  2013-01-09       Impact factor: 4.130

4.  Change in CSF Dynamics Responsible for ICP Elevation After Ischemic Stroke in Rats: a New Mechanism for Unexplained END?

Authors:  Mohammed S Alshuhri; Lindsay Gallagher; Christopher McCabe; William M Holmes
Journal:  Transl Stroke Res       Date:  2019-08-15       Impact factor: 6.829

5.  Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes.

Authors:  Andre D Kumar; Amelia K Boehme; James E Siegler; Michael Gillette; Karen C Albright; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-09-30       Impact factor: 2.136

6.  Identification of modifiable and nonmodifiable risk factors for neurologic deterioration after acute ischemic stroke.

Authors:  James E Siegler; Amelia K Boehme; Andre D Kumar; Michael A Gillette; Karen C Albright; T Mark Beasley; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-12-16       Impact factor: 2.136

7.  Systemic markers of inflammation are independently associated with S100B concentration: results of an observational study in subjects with acute ischaemic stroke.

Authors:  Christopher Beer; David Blacker; Michael Bynevelt; Graeme J Hankey; Ian B Puddey
Journal:  J Neuroinflammation       Date:  2010-10-29       Impact factor: 8.322

Review 8.  Inflammation in acute ischemic stroke and its relevance to stroke critical care.

Authors:  Hedley C A Emsley; Craig J Smith; Pippa J Tyrrell; Stephen J Hopkins
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

9.  Early changes in physiological variables after stroke.

Authors:  Andrew A Wong; Stephen J Read
Journal:  Ann Indian Acad Neurol       Date:  2008-10       Impact factor: 1.383

10.  Pontine infarction with pure motor hemiparesis or hemiplegia: a prospective study.

Authors:  Li Ling; Liangfu Zhu; Jinsheng Zeng; Songjie Liao; Suping Zhang; Jian Yu; Zhiyun Yang
Journal:  BMC Neurol       Date:  2009-06-15       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.